Cholestasis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials
• Forums

A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).
Conditions:   Progressive Familial Intrahepatic Cholestasis;   Alagille Syndrome;   Cholestatic Liver Disease Intervention:   Drug: Maralixibat Sponsor:   Mirum Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2021 Category: Research Source Type: clinical trials